Optogenetic modulation in stroke recovery

Neurosurgical Focus

Volumn 40, Issue 5, 2016, Pages

  Pendharkar, Arjun V ^a   Levy, Sabrina L ^a   Ho, Allen L ^a   Sussman, Eric S ^a   Cheng, Michelle Y ^a   Steinberg, Gary K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Designer receptor exclusively activated by designer drugs; DREADD; Ischemia; Neuroregeneration; Optogenetics; Plasticity; Stroke

Indexed keywords

ANIMAL; CONVALESCENCE; HUMAN; OPTOGENETICS; PHYSIOLOGY; PROCEDURES; STROKE; TRANSLATIONAL RESEARCH;

ANIMALS; HUMANS; OPTOGENETICS; RECOVERY OF FUNCTION; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84975275545     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: 10.3171/2016.2.FOCUS163     Document Type: Article

References (107)

1. Abilez OJ, Wong J, Prakash R, Deisseroth K, Zarins CK, Kuhl E: Multiscale computational models for optogenetic control of cardiac function. Biophys J 101:1326-1334, 2011
2. Alicke B, Schwartz-Bloom RD: Rapid down-regulation of GABAA receptors in the gerbil hippocampus following transient cerebral ischemia. J Neurochem 65:2808-2811, 1995
3. Aston-Jones G, Deisseroth K: Recent advances in optogenetics and pharmacogenetics. Brain Res 1511:1-5, 2013
4. Bentley JN, Chestek C, Stacey WC, Patil PG: Optogenetics in epilepsy. Neurosurg Focus 34(6):E4, 2013
5. Bernhardt J, Langhorne P, Lindley RI, Thrift AG, Ellery F, Collier J, et al: Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet 386:46-55, 2015
6. Bliss T, Guzman R, Daadi M, Steinberg GK: Cell transplantation therapy for stroke. Stroke 38 (2 Suppl):817-826, 2007
7. Bolognini N, Pascual-Leone A, Fregni F: Using non-invasive brain stimulation to augment motor training-induced plasticity. J Neuroeng Rehabil 6:8, 2009
8. Borlongan CV, Chopp M, Steinberg GK, Bliss TM, Li Y, Lu M, et al: Potential of stem/progenitor cells in treating stroke: the missing steps in translating cell therapy from laboratory to clinic. Regen Med 3:249-250, 2008
9. Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K: Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8:1263-1268, 2005
10. Boyle PM, Entcheva E, Trayanova NA: See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? Expert Rev Cardiovasc Ther 12:17-20, 2014
11. Busskamp V, Picaud S, Sahel JA, Roska B: Optogenetic therapy for retinitis pigmentosa. Gene Ther 19:169-175, 2012
12. Carmichael ST: Brain excitability in stroke: the yin and yang of stroke progression. Arch Neurol 69:161-167, 2012
13. Carmichael ST, Archibeque I, Luke L, Nolan T, Momiy J, Li S: Growth-associated gene expression after stroke: evidence for a growth-promoting region in peri-infarct cortex. Exp Neurol 193:291-311, 2005
14. Cavanaugh J, Monosov IE, McAlonan K, Berman R, Smith MK, Cao V, et al: Optogenetic inactivation modifies monkey visuomotor behavior. Neuron 76:901-907, 2012
15. Chang WH, Lin SK, Lane HY, Wei FC, Hu WH, Lam YW, et al: Reversible metabolism of clozapine and clozapine N-oxide in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 22:723-739, 1998
16. Chen Y, Xiong M, Zhang SC: Illuminating Parkinson's therapy with optogenetics. Nat Biotechnol 33:149-150, 2015
17. Cheng MY, Aswendt M, Steinberg GK: Optogenetic approaches to target specific neural circuits in post-stroke recovery. Neurotherapeutics [epub ahead of print], 2015
18. Cheng MY, Wang EH, Steinberg GK: Optogenetic approaches to study stroke recovery. ACS Chem Neurosci 5:1144-1145, 2014
19. Cheng MY, Wang EH, Woodson WJ, Wang S, Sun G, Lee AG, et al: Optogenetic neuronal stimulation promotes functional recovery after stroke. Proc Natl Acad Sci U S A 111:12913-12918, 2014
20. Chow BY, Boyden ES: Optogenetics and translational medicine. Sci Transl Med 5:177ps5, 2013
21. Chow BY, Han X, Dobry AS, Qian X, Chuong AS, Li M, et al: High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 463:98-102, 2010
22. Clarkson AN, Huang BS, Macisaac SE, Mody I, Carmichael ST: Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468:305-309, 2010
23. Daadi MM, Klausner JQ, Bajar B, Goshen I, Lee-Messer C, Lee SY, et al: Optogenetic stimulation of neural grafts enhances neurotransmission and downregulates the inflammatory response in experimental stroke model. Cell Transplant [epub ahead of print], 2015
24. Daadi MM, Maag AL, Steinberg GK: Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. PLoS One 3:e1644, 2008
25. Dai J, Ozden I, Brooks DI, Wagner F, May T, Agha NS, et al: Modified toolbox for optogenetics in the nonhuman primate. Neurophotonics 2:031202, 2015
26. Deisseroth K: Optogenetics: 10 years of microbial opsins in neuroscience. Nat Neurosci 18:1213-1225, 2015
27. Deng CX: The use of Cre-loxP technology and inducible systems to generate mouse models of cancer, in Green JE, Ried T (eds): Genetically Engineered Mice for Cancer Research. New York: Springer, 2012, pp 17-36
28. Diester I, Kaufman MT, Mogri M, Pashaie R, Goo W, Yizhar O, et al: An optogenetic toolbox designed for primates. Nat Neurosci 14:387-397, 2011
29. Emiliani V, Cohen AE, Deisseroth K, Häusser M: Alloptical interrogation of neural circuits. J Neurosci 35:13917-13926, 2015
30. Farrell R, Evans S, Corbett D: Environmental enrichment enhances recovery of function but exacerbates ischemic cell death. Neuroscience 107:585-592, 2001
31. Fenno L, Yizhar O, Deisseroth K: The development and application of optogenetics. Annu Rev Neurosci 34:389-412, 2011
32. Gaub BM, Berry MH, Holt AE, Isacoff EY, Flannery JG: Optogenetic vision restoration using rhodopsin for enhanced sensitivity. Mol Ther 23:1562-1571, 2015
33. George PM, Steinberg GK: Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron 87:297-309, 2015
34. Goings GE, Sahni V, Szele FG: Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury. Brain Res 996:213-226, 2004
35. Gorostiza P, Volgraf M, Numano R, Szobota S, Trauner D, Isacoff EY: Mechanisms of photoswitch conjugation and light activation of an ionotropic glutamate receptor. Proc Natl Acad Sci U S A 104:10865-10870, 2007
36. Gradinaru V, Mogri M, Thompson KR, Henderson JM, Deisseroth K: Optical deconstruction of parkinsonian neural circuitry. Science 324:354-359, 2009
37. Grefkes C, Fink GR: Connectivity-based approaches in stroke and recovery of function. Lancet Neurol 13:206-216, 2014
38. Guenthner CJ, Miyamichi K, Yang HH, Heller HC, Luo L: Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations. Neuron 78:773-784, 2013
39. Gunaydin LA, Yizhar O, Berndt A, Sohal VS, Deisseroth K, Hegemann P: Ultrafast optogenetic control. Nat Neurosci 13:387-392, 2010
40. Guo Z, Zhang L, Wu Z, Chen Y, Wang F, Chen G: In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer's disease model. Cell Stem Cell 14:188-202, 2014
41. Han X, Qian X, Bernstein JG, Zhou HH, Franzesi GT, Stern P, et al: Millisecond-timescale optical control of neural dynamics in the nonhuman primate brain. Neuron 62:191-198, 2009
42. Hao L, Zou Z, Tian H, Zhang Y, Zhou H, Liu L: Stem cell-based therapies for ischemic stroke. BioMed Res Int 2014:468748, 2014
43. Hiu T, Farzampour Z, Paz JT, Wang EH, Badgely C, Olson A, et al: Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target. Brain 139:468-480, 2015
44. Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, Encarnacion A, et al: Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29:274-285, 2011
45. Hummel F, Cohen LG: Improvement of motor function with noninvasive cortical stimulation in a patient with chronic stroke. Neurorehabil Neural Repair 19:14-19, 2005
46. Inoue K, Takada M, Matsumoto M: Neuronal and behavioural modulations by pathway-selective optogenetic stimulation of the primate oculomotor system. Nat Commun 6:8378, 2015
47. Jiang W, Xia F, Han J, Wang J: Patterns of Nogo-A, NgR, and RhoA expression in the brain tissues of rats with focal cerebral infarction. Transl Res 154:40-48, 2009
48. Kandori H: Ion-pumping microbial rhodopsins. Front Mol Biosci 2:52, 2015
49. Kawashima T, Okuno H, Bito H: A new era for functional labeling of neurons: activity-dependent promoters have come of age. Front Neural Circuits 8:37, 2014
50. Kelly S, Bliss TM, Shah AK, Sun GH, Ma M, Foo WC, et al: Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A 101:11839-11844, 2004
51. Kim TI, McCall JG, Jung YH, Huang X, Siuda ER, Li Y, et al: Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340:211-216, 2013
52. Kozlowski DA, James DC, Schallert T: Use-dependent exaggeration of neuronal injury after unilateral sensorimotor cortex lesions. J Neurosci 16:4776-4786, 1996
53. Krakauer JW, Carmichael ST, Corbett D, Wittenberg GF: Getting neurorehabilitation right: what can be learned from animal models? Neurorehabil Neural Repair 26:923-931, 2012
54. Kügler S, Kilic E, Bähr M: Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther 10:337-347, 2003
55. Lawlor PA, Bland RJ, Mouravlev A, Young D, During MJ: Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. Mol Ther 17:1692-1702, 2009
56. Lee HM, Giguere PM, Roth BL: DREADDs: novel tools for drug discovery and development. Drug Discov Today 19:469-473, 2014
57. Lee Y, Messing A, Su M, Brenner M: GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56:481-493, 2008
58. Levitz J, Pantoja C, Gaub B, Janovjak H, Reiner A, Hoagland A, et al: Optical control of metabotropic glutamate receptors. Nat Neurosci 16:507-516, 2013
59. Levy SL, White JJ, Sillitoe RV: Wheat germ agglutinin (WGA) tracing: a classic approach for unraveling neural circuitry, in Arenkiel BR (ed): Neural Tracing Methods: Tacing Neurons and Their Connections. New York: Spinger, Vol 92, 2015, pp 51-66
60. Li S, Nie EH, Yin Y, Benowitz LI, Tung S, Vinters HV, et al: GDF10 is a signal for axonal sprouting and functional recovery after stroke. Nat Neurosci 18:1737-1745, 2015
61. Li S, Overman JJ, Katsman D, Kozlov SV, Donnelly CJ, Twiss JL, et al: An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat Neurosci 13:1496-1504, 2010
62. Luhmann HJ: Ischemia and lesion induced imbalances in cortical function. Prog Neurobiol 48:131-166, 1996
63. Majid A: Neuroprotection in stroke: past, present, and future. ISRN Neurol 2014:515716, 2014
64. McIsaac RS, Bedbrook CN, Arnold FH: Recent advances in engineering microbial rhodopsins for optogenetics. Curr Opin Struct Biol 33:8-15, 2015
65. Mohajerani MH, Aminoltejari K, Murphy TH: Targeted mini-strokes produce changes in interhemispheric sensory signal processing that are indicative of disinhibition within minutes. Proc Natl Acad Sci U S A 108:E183-E191, 2011
66. Mohanty SK, Lakshminarayananan V: Optical techniques in optogenetics. J Mod Opt 62:949-970, 2015
67. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al: Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 131:e29-e322, 2015
68. Murphy TH, Corbett D: Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 10:861-872, 2009
69. Nagel G, Brauner M, Liewald JF, Adeishvili N, Bamberg E, Gottschalk A: Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Curr Biol 15:2279-2284, 2005
70. Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold P, et al: Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A 100:13940-13945, 2003
71. Neumann-Haefelin T, Hagemann G, Witte OW: Cellular correlates of neuronal hyperexcitability in the vicinity of photochemically induced cortical infarcts in rats in vitro. Neurosci Lett 193:101-104, 1995
72. Nowak DA, Grefkes C, Ameli M, Fink GR: Interhemispheric competition after stroke: brain stimulation to enhance recovery of function of the affected hand. Neurorehabil Neural Repair 23:641-656, 2009
73. Oh MS, Hong SJ, Huh Y, Kim KS: Expression of transgenes in midbrain dopamine neurons using the tyrosine hydroxylase promoter. Gene Ther 16:437-440, 2009
74. Ohab JJ, Carmichael ST: Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist 14:369-380, 2008
75. Ohab JJ, Fleming S, Blesch A, Carmichael ST: A neurovascular niche for neurogenesis after stroke. J Neurosci 26:13007-13016, 2006
76. Orban PC, Chui D, Marth JD: Tissue-and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A 89:6861-6865, 1992
77. Overman JJ, Carmichael ST: Plasticity in the injured brain: more than molecules matter. Neuroscientist 20:15-28, 2014
78. Park SI, Brenner DS, Shin G, Morgan CD, Copits BA, Chung HU, et al: Soft, stretchable, fully implantable miniaturized optoelectronic systems for wireless optogenetics. Nat Biotechnol 33:1280-1286, 2015
79. Qü M, Mittmann T, Luhmann HJ, Schleicher A, Zilles K: Long-term changes of ionotropic glutamate and GABA receptors after unilateral permanent focal cerebral ischemia in the mouse brain. Neuroscience 85:29-43, 1998
80. Reiner A, Isacoff EY: Photoswitching of cell surface receptors using tethered ligands. Methods Mol Biol 1148:45-68, 2014
81. Risedal A, Zeng J, Johansson BB: Early training may exacerbate brain damage after focal brain ischemia in the rat. J Cereb Blood Flow Metab 19:997-1003, 1999
82. Rogan SC, Roth BL: Remote control of neuronal signaling. Pharmacol Rev 63:291-315, 2011
83. Rongo C, Kaplan JM: CaMKII regulates the density of central glutamatergic synapses in vivo. Nature 402:195-199, 1999
84. Savitz SI, Cramer SC, Wechsler L: Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke 45:634-639, 2014
85. Schiene K, Bruehl C, Zilles K, Qü M, Hagemann G, Kraemer M, et al: Neuronal hyperexcitability and reduction of GABAA-receptor expression in the surround of cerebral photothrombosis. J Cereb Blood Flow Metab 16:906-914, 1996
86. Schmidt S, Bruehl C, Frahm C, Redecker C, Witte OW: Age dependence of excitatory-inhibitory balance following stroke. Neurobiol Aging 33:1356-1363, 2012
87. Shimizu T, Hosaki A, Hino T, Sato M, Komori T, Hirai S, et al: Motor cortical disinhibition in the unaffected hemisphere after unilateral cortical stroke. Brain 125:1896-1907, 2002
88. Simonelli F, Maguire AM, Testa F, Pierce EA, Mingozzi F, Bennicelli JL, et al: Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration. Mol Ther 18:643-650, 2010
89. Tsai SY, Markus TM, Andrews EM, Cheatwood JL, Emerick AJ, Mir AK, et al: Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke. Exp Brain Res 182:261-266, 2007
90. Tsai SY, Papadopoulos CM, Schwab ME, Kartje GL: Delayed anti-Nogo-A therapy improves function after chronic stroke in adult rats. Stroke 42:186-190, 2011
91. Tsubota T, Ohashi Y, Tamura K, Sato A, Miyashita Y: Optogenetic manipulation of cerebellar Purkinje cell activity in vivo. PLoS One 6:e22400, 2011
92. Vardy E, Robinson JE, Li C, Olsen RH, DiBerto JF, Giguere PM, et al: A new DREADD facilitates the multiplexed chemogenetic interrogation of behavior. Neuron 86:936-946, 2015
93. Vazey EM, Aston-Jones G: New tricks for old dogmas: optogenetic and designer receptor insights for Parkinson's disease. Brain Res 1511:153-163, 2013
94. Wahl AS, Omlor W, Rubio JC, Chen JL, Zheng H, Schröter A, et al: Neuronal repair. Asynchronous therapy restores motor control by rewiring of the rat corticospinal tract after stroke. Science 344:1250-1255, 2014
95. Waschuk SA, Bezerra AG Jr, Shi L, Brown LS: Leptosphaeria rhodopsin: bacteriorhodopsin-like proton pump from a eukaryote. Proc Natl Acad Sci U S A 102:6879-6883, 2005
96. Webster BR, Celnik PA, Cohen LG: Noninvasive brain stimulation in stroke rehabilitation. NeuroRx 3:471-481, 2006
97. Weick JP, Johnson MA, Skroch SP, Williams JC, Deisseroth K, Zhang SC: Functional control of transplantable human ESC-derived neurons via optogenetic targeting. Stem Cells 28:2008-2016, 2010
98. Whittle AJ, Walsh J, de Lecea L: Light and chemical control of neuronal circuits: possible applications in neurotherapy. Expert Rev Neurother 14:1007-1017, 2014
99. Wiessner C, Bareyre FM, Allegrini PR, Mir AK, Frentzel S, Zurini M, et al: Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab 23:154-165, 2003
100. Williams JC, Denison T: From optogenetic technologies to neuromodulation therapies. Sci Transl Med 5:177ps6, 2013
101. Xerri C, Zennou-Azogui Y, Sadlaoud K, Sauvajon D: Interplay between intra-and interhemispheric remodeling of neural networks as a substrate of functional recovery after stroke: adaptive versus maladaptive reorganization. Neuroscience 283:178-201, 2014
102. Yizhar O, Fenno LE, Davidson TJ, Mogri M, Deisseroth K: Optogenetics in neural systems. Neuron 71:9-34, 2011
103. Zhang F, Wang LP, Boyden ES, Deisseroth K: Channelrhodopsin-2 and optical control of excitable cells. Nat Methods 3:785-792, 2006
104. Zhang F, Wang LP, Brauner M, Liewald JF, Kay K, Watzke N, et al: Multimodal fast optical interrogation of neural circuitry. Nature 446:633-639, 2007
105. Zhang S, Boyd J, Delaney K, Murphy TH: Rapid reversible changes in dendritic spine structure in vivo gated by the degree of ischemia. J Neurosci 25:5333-5338, 2005
106. Zhao S, Ting JT, Atallah HE, Qiu L, Tan J, Gloss B, et al: Cell type-specific channelrhodopsin-2 transgenic mice for optogenetic dissection of neural circuitry function. Nat Methods 8:745-752, 2011
107. Zivin JA: Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA). Ann Neurol 66:6-10, 2009